Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-09

Clinical Trial Update: Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hypericin ointment with visible light for mycosis fungoides has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hypericin ointment (Hypericin)

Snippet

Sponsor: Ellen Kim, MD | Conditions: Cutaneous T Cell Lymphoma, Mycosis Fungoides | Phase 2 | Status: COMPLETED